AAA617, AAA517, Piflufolastat F 18, ARPI — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-23 in 3mo
ESTIMATED |
READOUT
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients
Phase 2 · Prostatic Neoplasm |
NVS NOVARTIS AG | AAA617, AAA517, Piflufolastat F 18, ARPI |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|